
[ Tue, Dec 05th 2017 ]: WOPRAI
[ Tue, Dec 05th 2017 ]: WOPRAI
[ Tue, Dec 05th 2017 ]: WOPRAI

[ Mon, Dec 04th 2017 ]: WOPRAI
[ Mon, Dec 04th 2017 ]: WOPRAI
[ Mon, Dec 04th 2017 ]: WOPRAI
[ Mon, Dec 04th 2017 ]: WOPRAI
[ Mon, Dec 04th 2017 ]: WOPRAI
[ Mon, Dec 04th 2017 ]: WOPRAI
[ Mon, Dec 04th 2017 ]: WOPRAI
[ Mon, Dec 04th 2017 ]: WOPRAI
[ Mon, Dec 04th 2017 ]: WOPRAI

[ Fri, Dec 01st 2017 ]: WOPRAI
[ Fri, Dec 01st 2017 ]: WOPRAI
[ Fri, Dec 01st 2017 ]: WOPRAI
[ Fri, Dec 01st 2017 ]: WOPRAI
[ Fri, Dec 01st 2017 ]: WOPRAI
[ Fri, Dec 01st 2017 ]: WOPRAI
[ Fri, Dec 01st 2017 ]: WOPRAI
[ Fri, Dec 01st 2017 ]: WOPRAI
[ Fri, Dec 01st 2017 ]: WOPRAI

[ Thu, Nov 30th 2017 ]: WOPRAI
[ Thu, Nov 30th 2017 ]: WOPRAI
[ Thu, Nov 30th 2017 ]: WOPRAI
[ Thu, Nov 30th 2017 ]: WOPRAI
[ Thu, Nov 30th 2017 ]: WOPRAI
[ Thu, Nov 30th 2017 ]: WOPRAI
[ Thu, Nov 30th 2017 ]: WOPRAI
[ Thu, Nov 30th 2017 ]: WOPRAI

[ Wed, Nov 29th 2017 ]: WOPRAI
[ Wed, Nov 29th 2017 ]: WOPRAI
[ Wed, Nov 29th 2017 ]: WOPRAI
[ Wed, Nov 29th 2017 ]: WOPRAI
[ Wed, Nov 29th 2017 ]: WOPRAI
[ Wed, Nov 29th 2017 ]: WOPRAI
[ Wed, Nov 29th 2017 ]: WOPRAI
[ Wed, Nov 29th 2017 ]: WOPRAI

[ Tue, Nov 28th 2017 ]: WOPRAI
[ Tue, Nov 28th 2017 ]: WOPRAI
[ Tue, Nov 28th 2017 ]: WOPRAI
[ Tue, Nov 28th 2017 ]: WOPRAI
[ Tue, Nov 28th 2017 ]: WOPRAI

[ Mon, Nov 27th 2017 ]: WOPRAI
[ Mon, Nov 27th 2017 ]: WOPRAI
[ Mon, Nov 27th 2017 ]: WOPRAI
[ Mon, Nov 27th 2017 ]: WOPRAI
[ Mon, Nov 27th 2017 ]: WOPRAI
[ Mon, Nov 27th 2017 ]: WOPRAI
Debjit Chattopadhyay Initiated (SRPT) at Strong Buy and Held Target at $75 on, Dec 1st, 2017


🞛 This publication is a summary or evaluation of another publication
Debjit Chattopadhyay of HC Wainwright & Co., Initiated "Sarepta Therapeutics, Inc." (SRPT) at Strong Buy and Held Target at $75 on, Dec 1st, 2017.
Debjit has made no other calls on SRPT in the last 4 months.
There are 3 other peers that have a rating on SRPT. Out of the 3 peers that are also analyzing SRPT, 1 agrees with Debjit's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Gena Wang of "Barclays" Maintained at Hold with Increased Target to $49 on, Thursday, October 26th, 2017
These are the ratings of the 2 analyists that currently disagree with Debjit
- Matthew Harrison of "Morgan Stanley" Upgraded from Hold to Buy on, Monday, October 2nd, 2017
- Alethia Young of "Credit Suisse" Maintained at Buy with Increased Target to $81 on, Thursday, September 7th, 2017
Similar Stocks and Investing Publications
[ Mon, Nov 13th 2017 ]: WOPRAI
[ Thu, Nov 09th 2017 ]: WOPRAI
[ Thu, Nov 09th 2017 ]: WOPRAI
[ Wed, Nov 08th 2017 ]: WOPRAI
[ Tue, Nov 07th 2017 ]: WOPRAI
[ Mon, Oct 30th 2017 ]: WOPRAI
[ Thu, Oct 26th 2017 ]: WOPRAI
[ Thu, Oct 26th 2017 ]: WOPRAI
[ Mon, Oct 02nd 2017 ]: WOPRAI
[ Thu, Dec 22nd 2016 ]: WOPRAI
[ Thu, Oct 27th 2016 ]: WOPRAI
[ Tue, Dec 01st 2015 ]: WOPRAI